These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Strategies to predict rheumatoid arthritis development in at-risk populations. Karlson EW; van Schaardenburg D; van der Helm-van Mil AH Rheumatology (Oxford); 2016 Jan; 55(1):6-15. PubMed ID: 25096602 [TBL] [Abstract][Full Text] [Related]
5. Imaging in the preclinical phases of rheumatoid arthritis. Zabotti A; Finzel S; Baraliakos X; Aouad K; Ziade N; Iagnocco A Clin Exp Rheumatol; 2020; 38(3):536-542. PubMed ID: 31376263 [TBL] [Abstract][Full Text] [Related]
6. Pre-RA: Can early diagnosis lead to prevention? Haville S; Deane KD Best Pract Res Clin Rheumatol; 2022 Mar; 36(1):101737. PubMed ID: 34991984 [TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to two novel peptides in seronegative and early rheumatoid arthritis. De Winter LM; Hansen WL; van Steenbergen HW; Geusens P; Lenaerts J; Somers K; Stinissen P; van der Helm-van Mil AH; Somers V Rheumatology (Oxford); 2016 Aug; 55(8):1431-6. PubMed ID: 27094600 [TBL] [Abstract][Full Text] [Related]
8. Is ACPA positivity the main driver for rheumatoid arthritis treatment? Pros and cons. Alivernini S; Galeazzi M; Peleg H; Tolusso B; Gremese E; Ferraccioli G; Naparstek Y Autoimmun Rev; 2017 Nov; 16(11):1096-1102. PubMed ID: 28899798 [TBL] [Abstract][Full Text] [Related]
9. First-degree relatives of patients with rheumatoid arthritis exhibit high prevalence of joint symptoms. Smolik I; Robinson DB; Bernstein CN; El-Gabalawy HS J Rheumatol; 2013 Jun; 40(6):818-24. PubMed ID: 23504380 [TBL] [Abstract][Full Text] [Related]
10. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis. van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872 [TBL] [Abstract][Full Text] [Related]
12. [The immunologic homunculus in rheumatoid arthritis. A new viewpoint of immunopathogenesis in rheumatoid arthritis and therapeutic consequences]. Bläss S; Engel JM; Burmester GR Z Rheumatol; 2001 Feb; 60(1):1-16. PubMed ID: 11263010 [TBL] [Abstract][Full Text] [Related]
13. Survivin improves the early recognition of rheumatoid arthritis among patients with arthralgia: A population-based study within two university cities of Sweden. Erlandsson MC; Turkkila M; Siljehult F; Pullerits R; Eriksson C; Rantapää-Dahlqvist S; Bokarewa MI Semin Arthritis Rheum; 2018 Jun; 47(6):778-785. PubMed ID: 29174794 [TBL] [Abstract][Full Text] [Related]
14. A prospective cohort study of 14-3-3η in ACPA and/or RF-positive patients with arthralgia. van Beers-Tas MH; Marotta A; Boers M; Maksymowych WP; van Schaardenburg D Arthritis Res Ther; 2016 Apr; 18():76. PubMed ID: 27037016 [TBL] [Abstract][Full Text] [Related]
15. Clinical and immunological aspects of anti-peptidylarginine deiminase type 4 (anti-PAD4) autoantibodies in rheumatoid arthritis. Reyes-Castillo Z; Muñoz-Valle JF; Llamas-Covarrubias MA Autoimmun Rev; 2018 Feb; 17(2):94-102. PubMed ID: 29196243 [TBL] [Abstract][Full Text] [Related]
16. DNA methylation mediates genotype and smoking interaction in the development of anti-citrullinated peptide antibody-positive rheumatoid arthritis. Meng W; Zhu Z; Jiang X; Too CL; Uebe S; Jagodic M; Kockum I; Murad S; Ferrucci L; Alfredsson L; Zou H; Klareskog L; Feinberg AP; Ekström TJ; Padyukov L; Liu Y Arthritis Res Ther; 2017 Mar; 19(1):71. PubMed ID: 28356135 [TBL] [Abstract][Full Text] [Related]
17. Differences in the symptomatic phase preceding ACPA-positive and ACPA-negative RA: a longitudinal study in arthralgia during progression to clinical arthritis. Burgers LE; van Steenbergen HW; Ten Brinck RM; Huizinga TW; van der Helm-van Mil AH Ann Rheum Dis; 2017 Oct; 76(10):1751-1754. PubMed ID: 28606964 [TBL] [Abstract][Full Text] [Related]
18. High-specificity bioinformatics framework for epigenomic profiling of discordant twins reveals specific and shared markers for ACPA and ACPA-positive rheumatoid arthritis. Gomez-Cabrero D; Almgren M; Sjöholm LK; Hensvold AH; Ringh MV; Tryggvadottir R; Kere J; Scheynius A; Acevedo N; Reinius L; Taub MA; Montano C; Aryee MJ; Feinberg JI; Feinberg AP; Tegnér J; Klareskog L; Catrina AI; Ekström TJ Genome Med; 2016 Nov; 8(1):124. PubMed ID: 27876072 [TBL] [Abstract][Full Text] [Related]
19. Rheumatoid Arthritis: The Continuum of Disease and Strategies for Prediction, Early Intervention, and Prevention. O'Neil LJ; Alpízar-Rodríguez D; Deane KD J Rheumatol; 2024 Apr; 51(4):337-349. PubMed ID: 38224993 [TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling in autoantibody-positive patients with arthralgia predicts development of arthritis. van Baarsen LG; Bos WH; Rustenburg F; van der Pouw Kraan TC; Wolbink GJ; Dijkmans BA; van Schaardenburg D; Verweij CL Arthritis Rheum; 2010 Mar; 62(3):694-704. PubMed ID: 20131234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]